Ligand · 0LG
0LG · N-[(4S,8E,11S)-4-[(1R)-1-hydroxy-2-{[3-(propan-2-yl)benzyl]amino}ethyl]-2,13-dioxo-11-phenyl-6-oxa-3,12-diazabicyclo[12.3.1]octadeca-1(18),8,14,16-tetraen-16-yl]-N-methylmethanesulfonamide
0LG, N-[(4S,8E,11S)-4-[(1R)-1-hydroxy-2-{[3-(propan-2-yl)benzyl]amino}ethyl]-2,13-dioxo-11-phenyl-6-oxa-3,12-diazabicyclo[12.3.1]octadeca-1(18),8,14,16-tetraen-16-yl]-N-methylmethanesulfonamide (C35 H44 N4 O6 S, 648.8 g/mol), in the MolNFT…
- Component
- 0LG
- Formula
- C35 H44 N4 O6 S
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
0LG in 2 structures; the first of them:
- 4DPF · BACE-1 in complex with a HEA-macrocyclic type inhibitor · 0LG A500 · binds GLY59, GLN60, LEU78, ASP80, GLY82, SER83, VAL117, PRO118 and 18 more
- 4DPF · Bace-1 in complex with a hea-macrocyclic type inhibitor · 0LG A500 · binds GLY59, GLN60, LEU78, ASP80, GLY82, SER83, VAL117, PRO118 and 18 more
Residues it binds most
ILE 2, GLY 2, THR 2, ARG 2, ASP 2, GLN 2, SER 2, TYR 2, ASN 2, LEU 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.